Empreses emergents
2021
ACCURE THERAPEUTICS SLEl futur dels tractaments del sistema nerviós central (SNC), avui Un enfocament diferent per al desenvolupament de fàrmacs per al SNC
Adreça
Carrer de Baldiri Reixac 15, 08028 Barcelona, Espanya
Xarxes socials

Dades financeres

DataInversorsQuantitatEtapa 
May 20207.600.000 €Series A
Jul 20191.336.170 €Early VC

Resum financer

Encara no s'han registrat ingressos
Series A

Contacte del Centre CERCA

Altres accionistes públics catalans

Logotip

Àrees d'estat i deeptech

Estat de l'empresa i àrees de tecnologia profunda de l'empresa

Estat de l'empresa

Estat de l'empresa

Àrea DeepTech

Àrea DeepTech

Informació sobre la spin-off

Descripció de l'empresa

Accure Therapeutics is a R&D pharma company dedicated to developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases, a major medical challenge.
Accure Therapeutics focuses on neurons that suffer a dysfunction, and on the glial environment that supports them, in an attempt to impede their degeneration and death. We work to find new medicines that correct the pathological changes that are responsible for the disease, and that produce beneficial outcomes (i.e. Disease Modifying Therapies). We specialize in developing drugs that promote neuroprotection and neurorepair by integrating the latest advances in neurobiology with state-of-the-art clinical research.

Descripció del producte

We support a targeted pipeline: We have currently built up a drug candidate portfolio that focuses on four areas:
Optic Neuritis
Multiple Sclerosis
Parkinson’s Disease
Epilepsy.